(Q38313390)
Statements
Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: an expert consensus (English)
Oliver Gautschi
Ekaterini Boleti
Paul Germonpré
Nicola Steele
Jesme Fox
Patrick Schnell
Arne Engelsberg
18 December 2014